CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2025-10-26 21:48Core Points - The company, Xiangsheng Medical, reported a stock price of 35.27 yuan, an increase of 4.75% as of October 24, 2025, with a trading volume of 38,400 shares and a turnover of 136 million yuan [1] - The company announced the results of its 2024 restricted stock incentive plan, confirming that 26 out of 30 incentive targets met the conditions for stock allocation, totaling 100,860 shares [2][4] - The company adjusted the grant price for the 2024 restricted stock incentive plan from 13.50 yuan to 12.50 yuan due to the completion of the 2024 profit distribution plan [2][8] Trading Information - On October 24, 2025, the net outflow of main funds was 2.0277 million yuan, while retail funds saw a net inflow of 2.7684 million yuan [1][3] Incentive Plan Details - The first vesting period for the 2024 restricted stock incentive plan is from October 23, 2025, to October 22, 2026, with a company-level vesting ratio of 92.11% based on a gross profit of 276.3152 million yuan for 2024 [2][4] - The company granted 160,000 shares of restricted stock to 17 incentive targets on October 23, 2025, at a price of 16.50 yuan per share, which represents 0.14% of the total share capital [5][6] Legal Compliance - The company confirmed that all incentive targets for the 2025 plan meet the legal qualifications and there are no disqualifying conditions as per relevant regulations [5][6][8] - The legal opinions provided by Shanghai Tongli Law Firm affirm that the adjustments and allocations comply with applicable laws and regulations [3][4][8]